Shaoqing Chen

• Over 14 years of drug discovery experience in big pharma and biotech companies. • Strong medicinal chemistry experience in oncology, metabolic diseases and inflammation. • Expertise in drug design in kinase inhibitors for anticancer drugs. • A track record of 19 patents and patent applications, 15 publications and presentations, and one book. • With three reagents on market: one CDK1 inhibitor in EMD Chemicals, two chemical reagents in Sigma-Aldrich. Specialties Organic synthesis, Medicinal chemistry, Structure-based drug design, Combinatorial chemistry, Kinase inhibitors.